UPDATE: Volpara Health Technologies has formed a partnership with US-based lung AI company, RevealDx, the second strategic play announced this month by the ASX-listed, Wellington-based cancer detection medtech to accelerate its move into the lung cancer screening market after establishing itself as
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
